Congenica, a digital health company that empowers precision medicine via its world-leading diagnostic decision support platform for genomic data, today announces the appointment of Robert Denison as Chief Executive Officer (CEO). He will also join the Board of the company.
Congenica sources added that Rob has a strong history of growing businesses ranging from start-ups to high-growth multi-billion-dollar organizations. He joined Congenica as Chief Information Officer (CIO) in Sept 2019 and since then has led the transformation of Congenica’s core technology into a robust cloud-based diagnostic data analysis and interpretation platform incorporating advanced AI and automation.
He also played a pivotal role in Congenica’s Series C fundraising for $50M. As CEO, Rob will be leading Congenica on its journey towards democratizing precision medicine at scale and delivering patient-led data processing and analytics.
Robert Denison stated of his appointment: “I am delighted to accept the role of CEO at Congenica, at what is a very exciting time for the business. Congenica is a global leader in genomics data analysis, working with the leading national genome programs and clinical laboratories across the world. With an excellent team in place, and supported by a global network of partners, we are well-positioned to deliver on our mission of enabling access to precision medicine for all.”
Dr. Andy Richards CBE, Chairman, Congenica, stated: “Rob is a highly accomplished leader who has demonstrated a deep commitment to Congenica. Under his leadership as CIO, he has positioned Congenica at the forefront of genomics data analysis. The Board are delighted that he has agreed to join as CEO and oversee Congenica’s continued growth and look forward to working with him as a director and member of the Board.”
